Segment Information (Tables)

12 Months Ended

Jun. 30, 2014

Financial Information Relating to Operating Segments

Following is financial information relating to the operating segments (in thousands):

	Year Ended June 30,
	2014			2013			2012
External sales
Biotechnology	$	300,578		$	288,156		$	293,274
Clinical Controls		57,185			22,419			21,286
Consolidated net sales	$	357,763		$	310,575		$	314,560
Earnings before taxes
Biotechnology	$	159,220		$	156,910		$	162,763
Clinical Controls		10,643			8,746			8,002
Segment earnings before taxes		169,863			165,656			170,765
Corporate		(8,471	)		(4,994	)		(8,570	)
Consolidated earnings before taxes	$	161,392		$	160,662		$	162,195
Goodwill
Biotechnology	$	95,124		$	84,336		$	85,682
Clinical Controls		56,349			0			0
Consolidated goodwill	$	151,473		$	84,336		$	85,682
Intangible assets, net
Biotechnology	$	53,778		$	40,552		$	46,476
Clinical Controls		54,998			0			0
Consolidated intangible assets, net	$	108,776		$	40,552		$	46,476

	Year Ended June 30,
	2014		2013		2012
Assets
Biotechnology	$	685,302	$	580,085	$	529,392
Clinical Controls		55,615		24,887		22,135
Segment assets		740,917		604,972		551,527
Corporate cash and available- for- sale investments		60,142		108,504		112,443
Corporate property and equipment		60,350		61,296		51,587
Corporate, other		1,082		3,326		3,767
Consolidated assets	$	862,491	$	778,098	$	719,324
Depreciation and amortization
Biotechnology	$	10,879	$	10,781	$	10,920
Clinical Controls		7,205		389		411
Segment depreciation and amortization		18,084		11,170		11,331
Corporate		1,091		1,151		1,136
Consolidated depreciation and amortization	$	19,175	$	12,321	$	12,467
Capital purchases
Biotechnology	$	4,157	$	3,248	$	4,021
Clinical Controls		5,687		6,914		597
Segment capital purchases		9,844		10,162		4,618
Corporate		3,977		12,292		1,399
Consolidated capital purchases	$	13,821	$	22,454	$	6,017

Financial Information Relating to Geographic Areas

Following is financial information relating to geographic areas (in thousands):

	Year Ended June 30,
	2014		2013		2012
External sales
United States	$	190,359	$	164,308	$	172,310
Europe		97,157		88,297		90,142
China		18,878		14,106		11,378
Other Asia		32,704		28,608		25,988
Rest of world		18,665		15,256		14,742
Total external sales	$	357,763	$	310,575	$	314,560
Long-lived assets
United States	$	109,790	$	103,541	$	87,968
Europe		8,340		7,129		7,528
China		678		117		141
Total long-lived assets	$	118,808	$	110,787	$	95,637